Morningstar Investor users sign in here.

iShares Biotechnology ETF IBB Strategy

The investment seeks to track the investment results of the NYSE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
The investment objective & strategy is a summary of the investment's principal strategy as written in the prospectus. This information is pulled from the most recent product disclosure document.

iShares Biotechnology ETF News & Analysis

funds

Are technology funds worth a look?

Like any other investment, you need to know what you own and why.

Markets

Index
Last price
Change
% Change
All Ordinaries 7,897.50 48.10 0.61%
CAC 40 7,957.57 42.92 0.54%
DAX 40 18,001.60 105.10 0.59%
Dow JONES (US) 38,675.68 450.02 1.18%
FTSE 100 8,213.49 41.34 0.51%
HKSE 18,475.92 268.79 1.48%
NASDAQ 16,156.33 315.37 1.99%
Nikkei 225 38,236.07 37.98 -0.10%
NZX 50 Index 11,938.08 64.04 0.54%
S&P 500 5,127.79 63.59 1.26%
S&P/ASX 200 7,629.00 42.00 0.55%
SSE Composite Index 3,104.82 8.22 -0.26%

Market Movers

Name
Last price
Change
% Change
Sigma Healthcare Ltd SIG 1.30 0.04 3.19%
South32 Ltd S32 3.58 0.03 0.85%
Zip Co Ltd ZIP 1.29 0.05 3.63%
Telstra Group Ltd TLS 3.58 0.01 -0.28%
Sayona Mining Ltd SYA 0.03 0.00 3.13%
Red 5 Ltd RED 0.43 0.01 -1.16%
Alumina Ltd AWC 1.56 0.04 2.30%
Evolution Mining Ltd EVN 3.73 0.22 -5.57%
Pilbara Minerals Ltd PLS 4.18 0.12 2.96%
The Star Entertainment Group Ltd SGR 0.44 0.03 6.10%